company background image
MAGNA logo

Magnasense OM:MAGNA Stock Report

Last Price

SEK 0.36

Market Cap

SEK 13.1m

7D

-11.1%

1Y

-75.3%

Updated

02 Aug, 2024

Data

Company Financials

MAGNA Stock Overview

A diagnostic company, develops and commercializes tests for monitoring and optimizing the dosage of biological drugs Sweden and internationally.

MAGNA fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Magnasense AB Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Magnasense
Historical stock prices
Current Share PriceSEK 0.36
52 Week HighSEK 1.66
52 Week LowSEK 0.35
Beta2.75
11 Month Change-15.47%
3 Month Change-24.35%
1 Year Change-75.26%
33 Year Change-99.90%
5 Year Changen/a
Change since IPO-96.54%

Recent News & Updates

Recent updates

Shareholder Returns

MAGNASE BiotechsSE Market
7D-11.1%-6.1%-0.6%
1Y-75.3%21.0%17.0%

Return vs Industry: MAGNA underperformed the Swedish Biotechs industry which returned 21% over the past year.

Return vs Market: MAGNA underperformed the Swedish Market which returned 17% over the past year.

Price Volatility

Is MAGNA's price volatile compared to industry and market?
MAGNA volatility
MAGNA Average Weekly Movement14.6%
Biotechs Industry Average Movement8.7%
Market Average Movement5.7%
10% most volatile stocks in SE Market12.1%
10% least volatile stocks in SE Market3.3%

Stable Share Price: MAGNA's share price has been volatile over the past 3 months.

Volatility Over Time: MAGNA's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Swedish stocks.

About the Company

FoundedEmployeesCEOWebsite
201914Marco Wititteveenwww.magnasense.com

Magnasense AB, a diagnostic company, develops and commercializes tests for monitoring and optimizing the dosage of biological drugs Sweden and internationally. The company focuses on the neurology, oncology, and autoimmune therapeutic areas. It offers moNATor, a first dose-monitoring laboratory test that provides multiple sclerosis for healthcare professionals and patients; and Viraspec, a COVID-19 saliva test kit.

Magnasense AB Fundamentals Summary

How do Magnasense's earnings and revenue compare to its market cap?
MAGNA fundamental statistics
Market capSEK 13.10m
Earnings (TTM)-SEK 49.38m
Revenue (TTM)SEK 36.00k

364.0x

P/S Ratio

-0.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MAGNA income statement (TTM)
RevenueSEK 36.00k
Cost of Revenue-SEK 92.00k
Gross ProfitSEK 128.00k
Other ExpensesSEK 49.50m
Earnings-SEK 49.38m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.37
Gross Margin355.56%
Net Profit Margin-137,155.56%
Debt/Equity Ratio-340.0%

How did MAGNA perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.